円
2785.00
Apr 26
Business Description
GL Sciences Inc
SIC : 111
ISIN : JP3385850007
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.97 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | 1.17 | |||||
Interest Coverage | 111.66 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.45 | |||||
Beneish M-Score | -2.32 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.9 | |||||
3-Year EBITDA Growth Rate | 27.8 | |||||
3-Year EPS without NRI Growth Rate | 27.6 | |||||
3-Year Book Growth Rate | 11.8 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.93 | |||||
9-Day RSI | 53.59 | |||||
14-Day RSI | 51.73 | |||||
6-1 Month Momentum % | 29.36 | |||||
12-1 Month Momentum % | 26.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.27 | |||||
Quick Ratio | 1.93 | |||||
Cash Ratio | 0.73 | |||||
Days Inventory | 183.83 | |||||
Days Sales Outstanding | 77.42 | |||||
Days Payable | 33.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.67 | |||||
Dividend Payout Ratio | 0.19 | |||||
3-Year Dividend Growth Rate | 26 | |||||
Forward Dividend Yield % | 5.03 | |||||
5-Year Yield-on-Cost % | 9.11 | |||||
Shareholder Yield % | -5.16 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 35.63 | |||||
Operating Margin % | 15.35 | |||||
Net Margin % | 9.15 | |||||
FCF Margin % | -3.14 | |||||
ROE % | 11.18 | |||||
ROA % | 6.62 | |||||
ROIC % | 9.59 | |||||
ROC (Joel Greenblatt) % | 18.35 | |||||
ROCE % | 15.04 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 8.37 | |||||
PE Ratio without NRI | 8.65 | |||||
Shiller PE Ratio | 13.54 | |||||
PEG Ratio | 0.5 | |||||
PS Ratio | 0.78 | |||||
PB Ratio | 0.89 | |||||
Price-to-Tangible-Book | 0.9 | |||||
Price-to-Operating-Cash-Flow | 14.38 | |||||
EV-to-EBIT | 4.63 | |||||
EV-to-EBITDA | 4.63 | |||||
EV-to-Revenue | 0.78 | |||||
EV-to-FCF | -23.91 | |||||
Price-to-Projected-FCF | 1.12 | |||||
Price-to-DCF (Earnings Based) | 0.54 | |||||
Price-to-Median-PS-Value | 1.19 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.43 | |||||
Price-to-Graham-Number | 0.59 | |||||
Price-to-Net-Current-Asset-Value | 2.74 | |||||
Earnings Yield (Greenblatt) % | 21.59 | |||||
FCF Yield % | -4.1 | |||||
Forward Rate of Return (Yacktman) % | 17.21 |